Question 1

What are the potential benefits of participating in this trial compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease clinical trial (NCT05878717). Contact the study team or your healthcare provider for specific answers.

Question 2

How will belimumab be administered, and what should I expect during the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease clinical trial (NCT05878717). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the possible side effects of belimumab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease clinical trial (NCT05878717). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease clinical trial (NCT05878717). Contact the study team or your healthcare provider for specific answers.

Question 5

What criteria will determine if I can participate in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease clinical trial (NCT05878717). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my lung function and other symptoms be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease clinical trial (NCT05878717). Contact the study team or your healthcare provider for specific answers.

What this study is about